Open an account

Stem Holdings

STMH · OTC

$0.00+$0.00 (+900.00%)TodayMarket closed ·
No price history for this range.

About STMH

Stem Holdings, Inc. is a cannabis branded products and technology company, which engages in the cultivation, processing, extraction, retail, distribution, and delivery-as-a-service (DaaS) operations of cannabis and cannabis-infused products. The company is headquartered in Boca Raton, Florida and currently employs 75 full-time employees. The company went IPO on 2018-05-18. Its family of brands includes TJ's Gardens, flower and extracts, and Cannavore edible confections. The firm has ownership interests in approximately 17 state issued cannabis licenses including nine licenses for cannabis cultivation, two licenses for cannabis processing, one licenses for cannabis wholesale distribution, and five cannabis dispensary licenses. The firm's subsidiaries include Stem Holdings Oregon, Inc., Stem Holdings IP, Inc., Opco, LLC, Stem Agri, Inc., Stem Holdings Oregon Acquisitions 1, Corp., Stem Holdings Oregon Acquisitions 2, Corp., Stem Holdings Oregon Acquisitions 3, Corp., Stem Holdings Oregon Acquisitions 4 Corp., and 2336034 Alberta Ltd.

Employees
75
Headquarters
Boca Raton, Florida
Listed
May 18, 2018
Sector
Health Care
Industry
Pharmaceuticals
Website
stemholdings.com

STMH key statistics

Market cap
1.27M
Price-earnings ratio
-0.00
Dividend yield
—
Average volume
2.27K
Volume
11
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.00
52 Week low
$0.00

Stem Holdings (STMH) at a glance

As of Aug 6, 2026, Stem Holdings (STMH) shares are priced at $0.00, giving the company a market cap of 1.27M and a price-to-earnings ratio of 0.00.

Volume so far is 11 shares, below the average of 2.27K shares a day.

Over the past year Stem Holdings has ranged from $0.00 to $0.00, and now sits 100% of the way up that range.

Stem Holdings met or beat analyst EPS estimates in 5 of the last 6 quarters. In Q3 FY22 it reported $0.00 per share against an estimate of -$0.0204.

STMH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 6 quarters, by 60.1% on average.

  1. Q2 FY21: reported -$0.06 per share against an estimate of -$0.0102
  2. Q3 FY21: reported $0.01 per share against an estimate of -$0.0612
  3. Q4 FY21: reported -$0.01 per share against an estimate of -$0.051
  4. Q1 FY22: reported -$0.02 per share against an estimate of -$0.0204
  5. Q2 FY22: reported -$0.02 per share against an estimate of -$0.0204
  6. Q3 FY22: reported $0.00 per share against an estimate of -$0.0204

Similar companies

Companies in the same industry as Stem Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.